(Q35803083)

10 August 2017

Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin (English)

1 reference

10 August 2017

1 reference

K T Kivistö

1

1 reference

10 August 2017

T Kantola

series ordinal

2

1 reference

10 August 2017

P J Neuvonen

series ordinal

3

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 July 1998

1 reference

British Journal of Clinical Pharmacology

10 August 2017

1 reference

10 August 2017

46

1 reference

10 August 2017

49-53

1 reference

10 August 2017

1

1 reference

Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873980

Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873980

Myositis and rhabdomyolysis associated with concurrent use of simvastatin and nefazodone

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873980

The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873980

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873980

Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873980

Efficacy and long-term adverse effect pattern of lovastatin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873980

Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873980

Determination of mevinolin and mevinolinic acid in plasma and bile by reversed-phase high-performance liquid chromatography

25 September 2018

1 reference

12 December 2020

The physiological disposition of lovastatin

1 reference

12 December 2020

Determination of itraconazole in serum with high-performance liquid chromatography and fluorescence detection

1 reference

12 December 2020

Biotransformation of lovastatin. IV. Identification of cytochrome P450 3A proteins as the major enzymes responsible for the oxidative metabolism of lovastatin in rat and human liver microsomes

1 reference

12 December 2020

[Rhabdomyolysis in patients treated with simvastatin and cyclosporin: role of the hepatic cytochrome P450 enzyme system activity]

1 reference

12 December 2020

Rhabdomyolysis from the coadministration of lovastatin and the antifungal agent itraconazole

1 reference

12 December 2020

In vivo inhibition profile of cytochrome P450TB (CYP2C9) by (+/-)-fluvastatin

1 reference

12 December 2020

Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid

1 reference

12 December 2020

Coadministration of itraconazole with hypolipidemic agents may induce rhabdomyolysis in healthy individuals

1 reference

12 December 2020

Drug-interaction-induced rhabdomyolysis

1 reference

12 December 2020

Evaluation of fluvastatin in the treatment of hypercholesterolemia in renal transplant recipients taking cyclosporine

1 reference

12 December 2020

10.1046/J.1365-2125.1998.00034.X

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

1 reference